A Phase I Clinical Trial of Vaccination With KIF20A-derived Peptide in Combination With Gemcitabine For Patients With Advanced Pancreatic Cancer

KIF20A (RAB6KIFL) belongs to the kinesin superfamily of motor proteins, which play critical roles in the trafficking of molecules and organelles during the growth of pancreatic cancer. Immunotherapy using a previously identified epitope peptide for KIF20A is expected to improve clinical outcomes. A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Suzuki, Nobuaki, Hazama, Shoichi, Ueno, Tomio, Matsui, Hiroto, Shindo, Yoshitaro, Iida, Michihisa, Yoshimura, Kiyoshi, Yoshino, Shigefumi, Takeda, Kazuyoshi, Oka, Masaaki
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3868021/
https://ncbi.nlm.nih.gov/pubmed/24316554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC3868021/
https://ncbi.nlm.nih.gov/pubmed/24316554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000012